Mark Izraelewicz to Speak at IP Defense Summit 2016 – Boston

November 3, 2016
Boston, MA

IP Litigation partner Mark H. Izraelewicz will be a roundtable speaker at the 2016 IP Defense Summit, to be held on Thursday, November 3, 2016, at The Colonnade Hotel, Boston. During the roundtable, which begins at 1:45 p.m. ET, industry professionals will lead discussions covering topics relating to the theme of “Defending IP in A Disruptive World.”  Mr. Izraelewicz will lead the discussion "Strategies to Avoid Willful Infringement Under the Evolving Standard for Willfulness.” Marshall Gerstein partner Thomas L. Duston will also be in attendance at the Summit.

For more than 15 years, Mark Izraelewicz has delivered winning results to clients such as Amgen and Eli Lilly. Mr. Izraelewicz leads the firm’s Hatch-Waxman pharmaceutical litigation practice. He has tried cases as a first-chair trial counsel, and argued appeals to the Federal Circuit. Mr. Izraelewicz’s success comes from his scientific background in synthetic organic chemistry, and experience prosecuting patent applications. Mr. Izraelewicz has represented Spectrum Pharmaceuticals in a series of litigations and at trial, including serving as Spectrum’s first-chair trial counsel in a January 2015 bench trial, and in the subsequent appeal, in a case concerning Spectrum’s oncology drug Fusilev®.